雲圖控股(002539.SZ):子公司擬申請尿素指定交割倉庫資質
格隆匯 11 月 24日丨雲圖控股(002539.SZ)公佈,公司於2020年11月23日召開第五屆董事會第十七次會議,審議通過了《關於全資子公司申請尿素指定交割倉庫資質的議案》,現將具體事項公告如下:
為滿足經營發展需要,促進主業快速穩定發展,公司之全資子公司嘉施利(寧陵)化肥有限公司(“寧陵嘉施利公司”)擬向鄭州商品交易所(“鄭商所”)申請尿素指定交割倉庫資質。經自查,公司與寧陵嘉施利公司的地域範圍、資質、財務狀況及其他條件符合鄭商所的相關要求。公司董事會同意上述事項,並授權寧陵嘉施利公司管理層及相關職能部門辦理此次申請事宜。
此次子公司申請尿素指定交割倉庫資質,將進一步提升公司及子公司的規範管理水平,助力公司穩定、持續發展。同時有利於公司將現貨市場、期貨市場、交割倉庫三者有機結合,進一步增強公司的應變能力、抗風險能力和競爭力,提高公司的經營效益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.